Autologous Transplantation in Relapsed and Refractory Mantle Cell Lymphoma

被引：0
|
作者：
Shah, Bijal D.
Little, Bryan J. [1 ]
Cultrera, Jennifer [2 ]
Bello, Celeste M. [3 ]
Sokol, Lubomir
Sotomayor, Eduardo M.
Tomblyn, Marcie [4 ]
Ayala, Ernesto
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Heme FOB3, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Hematopathol & Clin Med, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Tampa, FL 33682 USA
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4542.4542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma
    Colpo, Anna
    Hochberg, Ephraim
    Chen, Yi-Bin
    ONCOLOGIST, 2012, 17 (01): : 80 - 90
  • [22] Autologous stem cell transplantation for children and adolescents with relapsed and refractory Hodgkin's lymphoma
    Hedayati-Asl, A. A.
    Mehrvar, A.
    Faranoush, M.
    Dinarooni, P.
    Zangooei, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S602 - S602
  • [23] Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
    Wu, Aaron
    Graf, Solomon A.
    Burwick, Nicholas
    Grim, Jonathan E.
    Dong, Zhao Ming
    Richard, Robert E.
    Chauncey, Thomas R.
    BLOOD RESEARCH, 2020, 55 (01) : 57 - 61
  • [24] Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective
    Desai, Madhav
    Newberry, Kate
    Ou, Zhishuo
    Wang, Michael
    Zhang, Liang
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (03) : 91 - 101
  • [25] Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
    Maddocks, Kami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S187 - S188
  • [26] Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
    Shadman, Mazyar
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1331 - 1333
  • [27] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [28] Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Profile Report
    Hoy, Sheridan M.
    McKeage, Kate
    BIODRUGS, 2011, 25 (03) : 193 - 195
  • [29] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [30] A Systematic Review of Treatments of Relapsed/Refractory Mantle Cell Lymphoma
    Parrott, Madeliene
    Rule, Simon
    Kelleher, Michael
    Wilson, Jayne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 13 - +
12345